QISHLOQ AHOLISIDA ASOSIY YUQUMSIZ KASALLIKLARNING YETAKCHI XATAR OMILLARINING EPIDEMIOLOGIK TAVSIFLARI (ANDIJON MISOLIDA)
Article Sidebar
Main Article Content
Аннотация:
Xozirgi “uchinchi renessens” taraqqiyot davrida asosiy yuqumsiz kasalliklar (AYUK) ustidan nazorat tizimini takomillashtirishga oid zamonaviy yondashuvlarni ishlab chiqish masalasi, uning nazariy va ilmiy asoslarini ishlab chiqish mavzularni xalqaro miqyosida dolzarbligicha qolmoqda. Xattoki AYUK tarqalish tendensiyasi nafaqat turg‘unlashgan, balki tobora ko‘payib dolzarblashgan va yanada ko‘payib pandemik tus olib borishi yaqin kelajak davomida prognozlashgan.
Article Details
Как цитировать:
Библиографические ссылки:
Крысанова В.С., Келехсаев П.А. Социально – экономические аспекты проблемы избыточной массы тела и ожиреня. Лечебное дело. 2020;3:100 - 106. doi: 10.24412/2071 - 5315 - 2020 - 12264.
Ожирение. Клиническиерекомендации. 2020.URL: https://cr.minzdrav.gov.ru/recomend/28 2 (дата обращения: 28.03.2025).
Омельяновский В.В. Авсентьева М.В., Деркач Е.В., Свешникова Н.Д. Методические проблемы анализа стоимости болезни. Медицинские технологии. Оценки и выбор. 2011; 1:42 - 50. Оценка распространенности и эффективности коррекции факторов риска сердечно-сосудистых заболеваний среди врачей и их знания современных клинических рекомендаций. Результаты проекта «Здоровье и образование врача». Рациональная фармакотерапия в кардиологии. 2011 ;7(2): 137-144. doi: 10.20996/1819-6446- 2011-7-2-137-144.
Стрижелецкий В.В, Гомон Ю.М., Спичакова Е.А и др. Лекарственная терапия ожирения в Российской Федерации: фармакоэпидемиологическое исследование. Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. 2022; 15(3):320 - 331. doi: 10. 17749/2070 - 4909/farmakoekonomika. 2022.149.
Alshahrani NS, Hartley A, Howard J, Hajhosseiny R, Khawaja S, Selig- man H et al/ Randomized Trial of Remote Assessment of Patients Af¬ter an Acute Coronary Syndrome. Journal of the American College of Cardiology. 2024;83(23):2250-9. DOI: 10.1016/j jacc.2024.03.398.
Ayers JW, Poliak A, Dredze M, Leas EC, Zhu Z, Kelley JB et al. Com¬ paring Physician and Artificial Intelligence Chatbot Responses to Pa¬tient Questions Posted to a Public Social Media Forum. JAMA In¬ternal Medicine.2023; 183(6):589—96.DOI:10.1001/jamain-temmed.2023.1838. Bettcher D. Monitoring and surveillance of chronic non- communicable diseases: progress and capacity in high-burden countries. The Lancet. 2010;376(9755): 1861 -1868.doi: http.V/dx.doi.org/l 0.1016/SO 140-6736Г10)61853- 1
Boehmer JP, Cremer S, Abo-Auda WS, Stokes DR, Hadi A, Mc Cann PJ et al. Impact of a Novel Wearable Sensor on Heart Failure Rehospitalization:An Open-Label Concurrent-Control Clinical Tri¬al. JACC:Heart Failure.2024; 12(12):2011-22.DOI:10.1016/j.jchf.2024.07.022.
Cai Y, Yu F, Kumar M, et al. Health Recommender Systems Development, Usage, and Evaluation from 2010 to 2022: A Scoping Review. International Journal of Environmental Research and Public Health. 2022; 19(22): 15115. https://d0i.0rg/l0.3390/ijerph 192215115 12.
GBD 2016 Russia Collaborators. The burden of disease in Russia from
1980 to 2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392( 10153): 1 138 - 1146.
Hu J-R, Power JR, Zannad F, Lam CSP. Artificial intelligence and di¬gital tools for. design and execution of cardiovascular clinical trials. Eu¬ropean Heart Journal. 2024;ehae794. [Epub ahead of print]. DOI: 10.1093/eurheartj/ehae794.
Morley J, Murphy L, Mishra A, Joshi I, Karpathakis K. Gover¬ning Data and Artificial IntelligenceforHealth Care:Develo¬pingan International Understanding.JMIR Formative Research. 2022;6(l):e31623. DOI: 10.2196/31623.
Organization for Economic Co - operation and Development (OECD). The heavy burden of obesity: the economics of prevention. OECD Health Policy Studies. OECD publishing, Paris, 2019. doi: 10. 1787/67450d67 - en.
Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digital Medicine. 2020;3(1 ):17. DOI: 10.103 8/s41746-020-0221-y.
Vandenbroucke F, Michel M, Ackerman N, Briganti G. L’adoption de l’lntelligence Artificielle dans les hopitaux en Belgique. Barometer. 2022 26p. Av. at:https://www.msdconnect.be/fr/wp-content/up-loads/sites/15/2022/05/FR_BarometreIA_ Belgique.pdf.
World Health Organization Media Centre. Obesity and overweight. Fact sheet no Geneva: World Health Organization, 2021.
Wrzeciono A, Cieslik B, Kiper P, Szczepanska-Gieracha J, Gajda R. Ex¬ploratory analysis of the effectiveness of virtual reality in cardiovascu-lar rehabilitation. Scientific Reports. 2024; 14(1 ):281. DOI:10.1038/s41598-023-50788-9.
Xu M, Xu J, Yang X. Asthma and risk of cardiovascular disease or all¬cause mortality: a meta-analysis. Annals of Saudi Medicine. 2017;37(2):99-105. https://doi.om/10.5144/0256-4947.2011.99.
Yusefzadeh H., Rashidi A., Rahimi B. Economic burden of obesity: A systematic review. Social Health and Behavior. 2019;2( 1 ):7 - 12, doi: 10.4103/ShB.ShB_37_l 8.